Stop cheating jeez what a loser
<span>Reports communicate information which has been compiled as a result of research and analysis of data and of issues. So I think that variant B will be correct. What will be also useful for you is to be aware of the site where your report or a research paper may be written from the scratch or proofread. Check, please, Marvelous essay service. I am sure you can easily get the help there. </span>
Answer:
$412.5
Explanation:
First, we have to calculate the sale price of diamond at which i will be selling in normal circumstances
Normal selling price=Cost price+100%*Cost price
=275+100%*275
=$550
Now apply the discount rate of 25% to the normal selling price to caculate the actual offer price
Actual offer price=550*75%=$412.5
1. Add vibrant colours on key points to help them stand out.
2. Do not have too much text on your powerpoint slides; try to memorize your lines.
3. Use bullet points to clearly explain your aim.
Just some ideas :)
Answer:
BrisCor
Budgeting, ethics, pharmaceutical company
a. Referring to the "Standards of Ethical Behavior for Practitioners of Management Accounting and Financial Management,"
none of the preceding items are acceptable to use.
b. I would recommend Jackson to go ahead with the R&D throughout the year to ensure that the drug Vyacon was successfully brought to the market next year before the competitor. He can try to keep to the budget going forward. A budget remains a budget and not the actual. Budget overrun can result. What is important is its effectiveness in achieving business goals.
Explanation:
The announced expectations of third-quarter earnings to Wall Street analysts should not prevent the R&D on the drug Vyacon from continuing, provided Jackson is certain that the envisaged success would be attained. They remain expectations. They are not the actual results of operations for the year. Even if the company's stock price would tumble, it would still recover after the drug had received approval and gone to market, raking in large profits. After all, the projected increase in R&D cost might not result, and the drug Vyacon could be fully developed and ready for the market before year-end, thereby not exceeding its budget.
